维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Ohdo S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Statin inhibits the ex-pression of secretory phospholipase A2 and subsequentmonocyte chemoattractant protein-1 in human endothelialcells显示文摘	Sonoki K Iwase M Ohdo S	2014	J Cardiovasc Pharmacol2014，64，6：	1
2	Population based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update 显示文摘	Yukawa E Honda T Ohdo S	1997	J Clin Pharmacol1997，37，2：	1
3	Relations of lysophosphatidylcholine in low-density lipo- protein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in pa- tients with type 2 diabetes mellitns 显示文摘	Sonoki K Iwase M Sasaki N Ohdo S Hignchi S Matsuyama N	2009	Diabetes Res Clin Pract2009，86，2：	1
4	Telmisartan and N-aeetyleys- teine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity显示文摘	Sonoki K Iwase M Ohdo S	2012	J Cardiovase Pharmacol2012，60，4：	1
5	Chronopharmacology显示文摘	Ohdo S Koyanagi S Matsunaga N	2011	Nihon Yakurigaku Zasshi2011，137，3：	1
6	Population-Based investigation of valproic acid relative clearance using nonlinear mixed effects modeling:influence of drug-drug interaction and patient characteristics显示文摘	Yukawa E To H Ohdo S	1997	J Clin Pharmacol1997，37，：	1
7	Population-based investigation of Valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics显示文摘	YUKAWA E J TO H OHDO S	1997	J Clin Pharmacol1997，37，：	1
8	Chronotherapeutic strategy:Rhythm monitoring,manipulation and disruption显示文摘	Ohdo S	2010	Adv Drug Deliv Rev2010，62，：	1
9	Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics 显示文摘	Yukawa E To H Ohdo S	1997	J Clin Pharmacol1997，37，12：	1
10	Improving the ocular to systemic ratio of topi- cal timolol by varying the dosing time显示文摘	Ohdo S Grass GM Lee VH	1999	Invest Ophthalmol Vis Sci1999，32，10：	1
11	Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics显示文摘	Yukawa E To H Ohdo S	1997	J Clin Pharmacol1997，37，：	1
12	Chronopharmacology focused on biological clock显示文摘	Ohdo S		0，，：	1
13	Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update显示文摘	YUKAWA E HONDA T OHDO S	1997	Clin Pharmacol1997，37，2：	1
14	Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics 显示文摘	Yukawa EJ To H Ohdo S	1997	J Clin Pharmacol1997，37，：	1
15	Changes in toxicity and effectiveness with timing of drug administration implications for drug safety显示文摘	Ohdo S	2003	Drug Safety2003，26，14：	1
16	Changes in toxicity and effectiveness with timing of drug administration implications for drug safety显示文摘		2003	Drug Safety2003，26，14：	1
17	Chronopharmacology of antitumor effect induced by interferon-βin tumor-bearing mice显示文摘	Takane H Ohdo S Yamada T Yukawa E Higuchi S	2000	J Pharmacol Exp Ther2000，294，2：	1
18	Changes in toxicity and effectiveness with timing of drug administration implications for drug safety显示文摘	Ohdo S	2003	Drug Safety2003，26，14：	1
19	Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice 显示文摘	Wang D S Ohdo S Koyanagi S	2001	Antimicrob Agents Chemother2001，45，1：	1
20	Chronotherapeutic strategy:rhythm monitoring,manipulation and disruption显示文摘	Ohdo S		0，，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示